SERA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SERA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sera Prognostics's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was $-0.25. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.99.
Sera Prognostics's EPS (Diluted) for the three months ended in Dec. 2024 was $-0.25. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.99.
Sera Prognostics's EPS without NRI for the three months ended in Dec. 2024 was $-0.26. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -1.02.
During the past 3 years, the average EPS without NRI Growth Rate was 4.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 6 years, Sera Prognostics's highest 3-Year average EPS without NRI Growth Rate was 4.20% per year. The lowest was -15.10% per year. And the median was -3.90% per year.
The historical data trend for Sera Prognostics's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sera Prognostics Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
EPS (Basic) | Get a 7-Day Free Trial | -1.10 | -1.13 | -1.43 | -1.16 | -0.99 |
Sera Prognostics Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
EPS (Basic) | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.25 | -0.25 | -0.25 | -0.24 | -0.25 |
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Sera Prognostics's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as
Basic EPS (A: Dec. 2024 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-32.898 | - | 0) | / | 33.157 | |
= | -0.99 |
Sera Prognostics's Basic EPS for the quarter that ended in Dec. 2024 is calculated as
Basic EPS (Q: Dec. 2024 ) | = | (Net Income | - | Preferred Dividends) | / | Shares Outstanding (Basic Average) |
= | (-8.579 | - | 0) | / | 33.945 | |
= | -0.25 |
EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sera Prognostics (NAS:SERA) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Sera Prognostics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Austin Aerts | officer: Chief Financial Officer | 2479 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Robert Gardner Harrison | officer: Chief Information Officer | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Zhenya Lindgardt | director | C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 84109 |
John J. Boniface | officer: Chief Scientific Officer | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Mansoor Raza Mirza | director | C/O KARYOPHARM THERAPEUTICS INC., 2 MERCER ROAD, NATICK MA 01760 |
Benjamin Jackson | officer: General Counsel | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Paul Kearney | officer: Chief Data Officer | 2749 E. PARLEYS WAY, C/O SERA PROGNOSTICS, INC., SALT LAKE CITY UT 84109 |
Joshua Phillips | director | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Jane F Barlow | director | 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR, BOCA RATON FL 33487 |
Michael R Foley | officer: Chief Medical Officer | C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 04109 |
Sandra Aj Lawrence | director | C/O EVERGY, INC., 1200 MAIN STREET, KANSAS CITY MO 64105 |
Douglas Fisher | officer: Chief Business Officer | 587 PATROL RD, WOODSIDE CA 94062 |
Gregory C Critchfield | director, officer: Chief Executive Officer | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Blue Ox Healthcare Partners Sp, Llc | 10 percent owner | 135 E. 57TH STREET, 23RD FLOOR, NEW YORK NY 10022 |
Bxhcp Sp Ii, Llc | 10 percent owner | 135 E 57TH STREET, 23RD FLOOR, NEW YORK NY 10022 |
From GuruFocus
By GuruFocus News • 02-15-2025
By GuruFocus News • 01-15-2025
By PRNewswire • 03-19-2025
By PRNewswire • 02-11-2025
By PRNewswire • 05-08-2024
By PRNewswire • 10-28-2024
By PRNewswire • 08-07-2024
By GuruFocus Research • 08-07-2024
By GuruFocus News • 11-06-2024
By PRNewswire • 12-02-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.